Valuation dashboard for Connect Biopharma Holdings Limited (CNTB) with P/E N/A, P/B 2.31, EV/EBITDA -2.19 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody.
Analysis Summary
Trailing-twelve-month margins: gross margin 100.0%, operating margin -907.4%, net margin -866.9%.
At the current price of $1.24, CNTB has negative trailing earnings (P/E not meaningful) and an ROE of -132.16%. Market capitalisation stands at $78M.
Balance sheet quality for CNTB: current ratio of 3.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 2.31 |
| EV / EBITDA | -2.19 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.65 |
| vs Current Price | -47.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CNTB | Connect Biopharma Holdings Limited | $78M | 2.31 | -132.2% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $1.24 |
| Market Cap | $78M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -132.16% |
| Return on Invested Capital | -135.74% |
| Return on Assets | -98.94% |
| Gross Margin | 100.00% |
| Operating Margin | -90740.62% |
| Net Margin | -86687.50% |
Related companies: ARTV · CNTX · IFRX · IMA · KLRS · MGX · OVID
Explore sector: Healthcare · Biotechnology
More sections of CNTB: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks